Institutional investors purchased a net $272.5 thousand shares of CVM during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 7.33% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
KCG AMERICAS LLC Bought 138.8 Thousand shares of CEL-SCI Corp
THE VANGUARD GROUP, INC. Bought 84.1 Thousand shares of CEL-SCI Corp
GEODE CAPITAL MANAGEMENT LLC Bought 77.1 Thousand shares of CEL-SCI Corp